Literature DB >> 29382864

Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection.

Majela González-Miró1,2, Laura M Rodríguez-Noda2, Mildrey Fariñas-Medina2, Barbara Cedré-Marrero2, Sandra Madariaga-Zarza2, Caridad Zayas-Vignier2, Mabel Hernández-Cedeño2, Torsten Kleffmann3, Dagmar García-Rivera2, Vicente Vérez-Bencomo2, Bernd H A Rehm4,5.   

Abstract

The efficacy of protein and carbohydrate antigens as vaccines can be improved via particulate delivery strategies. Here, protein and carbohydrate antigens used in formulations of vaccines against Neisseria menigitidis were displayed on in vivo assembled polyester beads using a combined bioengineering and conjugation approach. An endotoxin-free mutant of Escherichia coli was engineered to produce translational fusions of antigens (Neisseria adhesin A (NadA) and factor H binding protein (fHbp) derived from serogroup B) to the polyhydroxybutyrate synthase (PhaC), in order to intracellularly assemble polyester beads displaying the respective antigens. Purified beads displaying NadA showed enhanced immunogenicity compared to soluble NadA. Both soluble and particulate NadA elicited functional antibodies with bactericidal activity associated with protective immunity. To expand the antigen repertoire and to design a more broadly protective vaccine, NadA-PhaC beads were additionally conjugated to the capsular polysaccharide from serogroup C. Co-delivery of surface displayed NadA and the capsular polysaccharide induced a strong and specific Th1/Th17 mediated immune response associated with functional bactericidal antibodies. Our findings provide the foundation for the design of multivalent antigen-coated polyester beads as suitable carriers for protein and polysaccharide antigens in order to induce protective immunity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29382864      PMCID: PMC5789850          DOI: 10.1038/s41598-018-20205-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  72 in total

1.  Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors.

Authors:  Theodora Fifis; Anita Gamvrellis; Blessing Crimeen-Irwin; Geoffrey A Pietersz; Jie Li; Patricia L Mottram; Ian F C McKenzie; Magdalena Plebanski
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

2.  Despite successful vaccines Neisseria meningitidis strikes again.

Authors:  Susanne Jacobsson
Journal:  Lancet Infect Dis       Date:  2016-08-23       Impact factor: 25.071

3.  Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.

Authors:  C L Vermont; H H van Dijken; C J P van Limpt; R de Groot; L van Alphen; G P J M van Den Dobbelsteen
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  MHC class I- and class II-restricted processing and presentation of microencapsulated antigens.

Authors:  Y Men; R Audran; C Thomasin; G Eberl; S Demotz; H P Merkle; B Gander; G Corradin
Journal:  Vaccine       Date:  1999-03-05       Impact factor: 3.641

Review 5.  Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.

Authors:  Wenlei Jiang; Rajesh K Gupta; Mangesh C Deshpande; Steven P Schwendeman
Journal:  Adv Drug Deliv Rev       Date:  2005-01-10       Impact factor: 15.470

Review 6.  Novel particulate vaccines utilizing polyester nanoparticles (bio-beads) for protection against Mycobacterium bovis infection - a review.

Authors:  Natalie A Parlane; Bernd H A Rehm; D Neil Wedlock; Bryce M Buddle
Journal:  Vet Immunol Immunopathol       Date:  2013-04-30       Impact factor: 2.046

7.  Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.

Authors:  H Peltola; H Mäkelä; H Käyhty; H Jousimies; E Herva; K Hällström; A Sivonen; O V Renkonen; O Pettay; V Karanko; P Ahvonen; S Sarna
Journal:  N Engl J Med       Date:  1977-09-29       Impact factor: 91.245

8.  Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System.

Authors:  G Martínez-Donato; B Piniella; D Aguilar; S Olivera; A Pérez; Y Castañedo; L Alvarez-Lajonchere; S Dueñas-Carrera; J W Lee; N Burr; M Gonzalez-Miro; B H A Rehm
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

9.  Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay.

Authors:  L L Gheesling; G M Carlone; L B Pais; P F Holder; S E Maslanka; B D Plikaytis; M Achtman; P Densen; C E Frasch; H Käyhty
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

10.  Engineering Mycobacteria for the Production of Self-Assembling Biopolyesters Displaying Mycobacterial Antigens for Use as a Tuberculosis Vaccine.

Authors:  Jason W Lee; Natalie A Parlane; Bernd H A Rehm; Bryce M Buddle; Axel Heiser
Journal:  Appl Environ Microbiol       Date:  2017-02-15       Impact factor: 4.792

View more
  6 in total

Review 1.  Bioengineered Polyhydroxyalkanoates as Immobilized Enzyme Scaffolds for Industrial Applications.

Authors:  Jin Xiang Wong; Kampachiro Ogura; Shuxiong Chen; Bernd H A Rehm
Journal:  Front Bioeng Biotechnol       Date:  2020-03-04

Review 2.  Polymeric nanoparticle vaccines to combat emerging and pandemic threats.

Authors:  David Wibowo; Sytze H T Jorritsma; Zennia Jean Gonzaga; Benjamin Evert; Shuxiong Chen; Bernd H A Rehm
Journal:  Biomaterials       Date:  2020-12-10       Impact factor: 12.479

Review 3.  Hijacking Factor H for Complement Immune Evasion.

Authors:  Sara R Moore; Smrithi S Menon; Claudio Cortes; Viviana P Ferreira
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

4.  Ambient Temperature Stable, Scalable COVID-19 Polymer Particle Vaccines Induce Protective Immunity.

Authors:  Shuxiong Chen; Benjamin Evert; Adetayo Adeniyi; Mercè Salla-Martret; Linda H-L Lua; Victoria Ozberk; Manisha Pandey; Michael F Good; Andreas Suhrbier; Peter Halfmann; Yoshihiro Kawaoka; Bernd H A Rehm
Journal:  Adv Healthc Mater       Date:  2021-11-10       Impact factor: 11.092

5.  Engineering Antigens to Assemble into Polymer Particle Vaccines for Prevention of Streptococcus suis Infection.

Authors:  Zennia Jean C Gonzaga; Shuxiong Chen; Mélanie Lehoux; Mariela Segura; Bernd H A Rehm
Journal:  Vaccines (Basel)       Date:  2021-11-24

6.  Inhibition of Listeria monocytogenes by Phage Lytic Enzymes Displayed on Tailored Bionanoparticles.

Authors:  Edel Stone; Vincenzo Pennone; Kerri Reilly; Irene R Grant; Katrina Campbell; Eric Altermann; Olivia McAuliffe
Journal:  Foods       Date:  2022-03-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.